ABSTRACT. The deficiency of pyruvate dehydrogenase enzyme complex causes congenital lactic acidemia and devastating neurologic abnormalities in newborns and children. In the majority of cases, the basic defect appears to be in the pyruvate dehydrogenase (El) component, which consists of two subunits, a and p. Whereas some patients are deficient of a single subunit, in other patients both subunits of El are missing. To find out why two proteins were deficient, we investigated the cultured fibroblasts of a female patient who had missing El-a and El-@ protein bands on Western blot. Radiolabeling-immunoprecipitation studies with 35S-methionine revealed that patient fibroblasts synthesized normal sized precursor El-a and El-, 8 proteins, which were presumably transported into mitochondria and processed into normal sized mature proteins. However, pulse-chase analysis showed that a -and @-proteins were degraded rapidly compared to normal. Our findings proved that a-and ,&subunits were synthesized and processed normally but failed to form a stable structure for incorporation into the pyruvate dehydrogenase complex. (Pediatr Res 30: [11][12][13][14] 1991) 
I
El, E2, E3, and their cofactor binding sites, and defects of activation of PDHC could lead to PDHC deficiency (4, 5) . Deficiencies of nuclear-coded polypeptides may be due to reduced synthesis, increased rate of degradation, or defective transport of protein precursors from cell cytosol to mitochondria. One aspect still awaiting definition is different subunit defects possible in El deficiency (6). There is heterogeneity in the expression of El deficiency at the protein level. Examination of deficient cell lines at the level of mRNA by Northern blotting techniques indicated that, although in some patients the defect was in the synthesis of El protein, in other patients the defect could be due to some other mechanisms (7). In some patients, both El-a and El-@ were deficient (7-9). To find the mechanism of combined deficiency, we investigated the synthesis, mitochondrial import, processing, and rate of degradation of both proteins in cultured fibroblasts of a patient with PDHC deficiency.
MATERIALS AND METHODS
Brief case report. The patient was a girl born at the 38th wk of an uncomplicated pregnancy. The birth weight was 2590 g. Neither of the parents had any problem. The patient presented with poor feeding, muscle weakness, developmental retardation, and lactic acidosis. Serum lactic and pyruvic acid levels were 4.57 mmol/L (41.2 mg/dL) and 0.44 mmol/L (3.89 mg/dL), respectively. Urine organic acids and plasma amino acids were uninformative. At 8 mo of age, she developed infantile spasm. Computed tomography scan showed total brain atrophy. EEG showed diffuse spikes and waves. At 4 y 9 mo of age, enzyme studies on a biopsy specimen of muscle and cultured fibroblasts showed PDHC deficiency (10). The original and dichloroacetic acid-activated activities were 20 and 9% of normal, respectively. Total activity of PDHC, measured after in vitro activation with an excess amount of a broad specificity phosphatase, was 16% of normal. The patient was maintained on a respirator from 6 y of age until her death at the age of 8 y.
Materials. L-35S-methionine (>800 Ci/mmol) and I4C-labeled protein standard were purchased from Amersham Corp. (Arlington Heights, IL). Formalin-fixed Staphylococcus aureus cells were from Bethesda Research Laboratories (Bethesda, MD). Rhodamine 6G, x-ray film, X-Omat R, and film cassettes were from Eastman Kodak Co. (Rochester, NY). The immunoblot system was purchased from Bio-Rad Laboratories (Richmond, CA). Cycloheximide, phenylmethanesulphonyl fluoride, p-aminobenzamidine, and leupeptin were purchased from Sigma Chemical Co. (St. Louis, MO). Cell culture materials were from Nissui, Tokyo, Japan.
Preparation of antibodies against PDHC and El-a and El-@ proteins. The PDHC was purified from ox heart by the method of Stanley and Perham (1 I). On SDS-PAGE, PDHC gave the following bands: El-@, El-&, E2, E3, and X. The different com~u r t u d ponents were separated by SDS-PAGE and capillary endomosis 9 h -Fibroblast using the electro-elutor ELFE as described in the manual (Gen-
ofit, Switzerland). Rabbit antibodies were prepared against F F PDHC El-a and El-P proteins using standard procedures. 
; X
protein at -80°C until use. SDS-PAGE was done with 10% separating gel and 4% stacking gel as described by Laemmli (12).
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After separation by SDS-PAGE, proteins were transblotted to nitrocellulose membranes as described in the instruction manual. The blots were blocked in Tris-buffered saline containing 3% h p -. -nonfat dry milk and incubated for 1 h in anti-PDHC antibody Pulse-labeling of fibroblasts with 35S-methionine and pulse-fibroblast mitochondria (50 ~g protein/sample) were separated by SDSchase. confluent monolayers of fibroblasts in a 25-cm2 flask were PAGE and electroblotted to a filter membrane. PDHC components were labeled with 3 5~-~~t h i~~i~~ (50 p~i ) in 2.5 m~ of labeling detected with anti-PDHC antibodies and a Bio-Rad antirabbit immumedium containing 60% pucvs saline G, 15% dialyzed FCS, noblot horseradish peroxidase kit. Lane 1, purified ox heart PDHC (300 and 10% glucose (12). optimum labeling for E~-P and ng protein). Lanes 2 and 4, mitochondrial extract from normal fibrooccurred when the culture flasks were incubated 1 h and 4 h, blasts. Lane 3, mitochondrial extract from PDHC-deficient fibroblasts. respectively. After incubation, the labeling medium was removed and cells were washed twice with PBS and then harvested by
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wT--2 adding 5 mL of NETSImethionine buffer (150 mM NaCl, 10 mM EDTA, pH 7.4, 0.5% Triton X-100, 0.25% SDS, and 2% unlabeled methionine) to each flask. When studying the precur- 'SS-methionine incorporation into total proteins was measured Immunochemical analysis. Figure 1 shows the immunoblot of rated protein, 10' dpm) were analyzed by 10% SDS-PAGE and fluorog-SDS-PAGE of purified bovine PDHC (lane I ) and mitochondria1 raphy. A, lanes 2 and 4, mature El-cu protein from normal fibroblasts. A, extract from normal (lanes 2 and 4) and PDHC-deficient (lane lane 3, mature El-cu protein from patient fibroblasts. B, lanes I and 3,  3 ) fibroblasts. Mitochondria1 extract of normal fibroblasts gave precursor El-a protein from normal fibroblasts. B, lane 2, precursor Elfour bands corresponding to components E2, X, El-a and El$. Patient fibroblasts gave normal E2 and X bands, but El-a and standard molecular weight markers. El-P bands were missing. The E3 band could not be detected by Western blot analysis in either patient or in normal fibroblasts leading to the suppression of their posttranslational processing because of its low immunogenecity. Western blot analysis using (13-15). In normal fibroblasts, when El-a protein was labeled in monospecific antibodies against El-a and El+ confirmed ab-absence of rhodamine 6G, a sharp band with a molecular weight sence of El-a and El-@ bands in patient fibroblasts (result not of 42 kD was observed ( Fig. 2A, lanes 2 and 4) . In patient shown).
fibroblasts, the band had the same molecular weight but was Electrophoretic analysis ofEl-a and El$ proteins labeled with consistently more intense (Fig. 2A, lane 3) . When cell labeling 35S-methionine. We studied the synthesis and mitochondrial was performed in the presence of rhodamine 6G, the 42-kD import of the precursors of a-and P-subunits of El protein in band was not present and a new 44.5-kD band for precursor normal and patient fibroblasts by labeling with 35S-methionine protein was detected in both normal and patient fibroblasts ( 1, 2, and 3) . In Figures 2A and B , the bands in the the mitochondrial energy metabolism, is known to inhibit the patient's lanes were more intense than those of the corresponding uptake of precursor of nuclear-encoded mitochondrial enzymes, control. This might reflect increased synthesis or altered immu-UNSTABLE PYRUVATE DEHYDROGENASE PROTEIN 13 noreactivity of a variant El-a protein. Both 42-and 44.5-kD bands were not detectable when an excessive amount of pure El-a was added to each immunoprecipitation mixture before the addition of antibody (result not shown). This confirms that 42-and 44.5-kD bands were indeed the mature and precursor El-a, respectively.
Using anti-El-@ antibody, a 36-kD band was detected in both normal and patient fibroblasts (Fig. 3, lanes 1 and 3 ) when labeling was done in the absence of rhodamine 6G. When labeling was done in the presence of rhodamine 6G, the 36-kD band was not present, and a new 39-kD band for precursor protein was detected in both normal and patient fibroblasts (Fig.  3, lanes 2 and 4) . Both 36-and 39-kD bands disappeared when excess El-@ protein was added to each immunoprecipitation mixture before the addition of antibody (result not shown).
Pulse-labeling chase experiment. To investigate the rate of degradation, we pulse-labeled El-a protein for 4 h with 35S-methionine and then chased the labeled El-a for various periods. The density of the fluorographic band for El-a remained the same at 24 h of chase in the normal fibroblast line (Fig. 4 , lane 2) but decreased markedly in the patient fibroblasts (Fig. 4, lane  5) . The El-a protein band in patient fibroblasts almost disappeared after 48 h, although the band in the normal fibroblasts did not change much. In the normal fibroblasts, the fluorographic band was clearly detectable even after 10 d (result not shown).
Similarly, we did a pulse-chase experiment for El-@ protein (Fig. 5) . The density of the fluorographic band for El-@ protein remained comparable at 24 h (result not shown) and decreased progressively at 48 and 96 h, but was clearly detectable at 96 h in the normal fibroblast line (Fig. 5A, lanes 1-3) . In the normal fibroblast line, the fluorographic band was detectable even after 10 d (result not shown). The patient fibroblast line, after 1 h of pulse-labeling, synthesized El-@ protein in an amount comparable to the normal fibroblast line (Fig. 5B, lane 1) . However, the fluorographic band was barely detectable after 48 h of chase (Fig. 5B, lane 2) and could not be detected after 96 h of chase (Fig. 5B, lane 3) , even when the film was exposed for a long time. , lanes 1-3, normal. B, lanes 1-3,  patient. A and B, lane I, immediately after 1 h of pulse. Lane 2, after 48 h of chase. Lane 3, after 96 h of chase.
DISCUSSION
We investigated cultured fibroblasts from a patient with PDHC deficiency. Immunoblot and radiolabeling-pulse-chase experiments showed increased degradation of El-a and El-@ subunits.
Deficiency of PDHC is the most common of the disorders leading to congenital lactic acidemia (6). More than 100 cases of this deficiency have been described in the literature ( I 6). In the majority of cases, the basic defect appears to be in the El protein, and different patterns of El deficiency have been detected (6-9). In one group, there are immunologically detectable El-a and El-@ with normal mRNA levels. A second group has diminished amounts of both immunoreactive proteins, but normal levels of mRNA for both subunits. In another group, immunologically detectable El-a and El+ proteins are diminished, but with reduced levels of mRNA for El-a only. In a fourth group there are few cases of isolated El-a deficiency. It is striking that only El-a or combined deficiency have been reported. The phosphorylation sites for regulation of the whole complex are on the El-a subunit; it may be that a defect involving the El-@ chain would not have the same severe consequences as a lack of or a disturbance of phosphorylation of a-subunit.
It is interesting that both El-a and El-@ proteins were deficient in our patient and in some reported cases (7, 8). El-a and El-@ proteins are encoded by different genes (17) . This excludes the possibility that a common mRNA and protein exist from which El-& and El-@ are derived. The chances that there were simultaneous mutations in two different genes encoding both the subunits in a group of unrelated patients are very small. However, there are instances in biology where a single gene defect causes multiple missing proteins (18). A single gene defect that results in deficiencies of both subunits of the El protein could have several explanations: 1) mutation in a regulatory gene that controls the synthesis of a -and @-subunits; 2) a common defect in mitochondria1 import and processing of both proteins; and 3) failure to form a stable a&-tetramer for incorporation into PDHC resulting in the degradation of unassociated subunit proteins. A similar case is found in CAMP-dependent protein kinase, where the degradation of the regulatory subunit I is increased 10 times in absence of the catalytic subunit (19).
In this study, immunoblot analysis of PDHC revealed that immuno-cross-reactive El-a and El-@ were absent, indicating that the steady state amount of a-and @-subunits within fibroblasts were very low. However, radiolabeling studies revealed that the same fibroblast line could produce 35S-methioninelabeled El-a and El-@ in amounts comparable to those of normal fibroblast lines. This indicated that patient fibroblasts produced El-a and El-@ proteins that were extremely labile compared to normal proteins. Pulse-chase experiments also confirmed that aand @-proteins were degraded more rapidly in patient fibroblasts than in normal fibroblasts. The half-life of the precursor protein in cytosol may be shorter than that of the mature form in the mitochondria. However, in patient fibroblasts, El-a and El-@
